1. An adolescent case of familial hyperparathyroidism with a germline frameshift mutation of the CDC73 gene
- Author
-
Akihiro Sakurai, Hotaka Kamasaki, Takeshi Tsugawa, Jiro Ogino, Shinya Uchino, Atsushi Kondo, Sawa Anan, Aki Ishikawa, Yuko Yoto, Hiroyuki Tsutsumi, Takako Takeuchi, Tadashi Hasegawa, and Naoya Yama
- Subjects
medicine.medical_specialty ,endocrine system diseases ,business.industry ,Endocrinology, Diabetes and Metabolism ,Thyroid ,medicine.disease ,Asymptomatic ,Gastroenterology ,Germline ,Frameshift mutation ,Endocrinology ,medicine.anatomical_structure ,Parathyroid carcinoma ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,medicine.symptom ,business ,hormones, hormone substitutes, and hormone antagonists ,Primary hyperparathyroidism ,Aunt ,Parathyroid adenoma - Abstract
A 13-yr-old boy who complained of persistent nausea, vomiting and weight loss had hypercalcemia and an elevated intact PTH level. Computed tomography confirmed two tumors in the thyroid gland. The tumors were surgically removed and pathologically confirmed as parathyroid adenoma. Because his maternal aunt and grandmother both had histories of parathyroid tumors, genetic investigation was undertaken for him, and a germline frameshift mutation of the CDC73 gene was identified. CDC73 gene analysis should be done on individuals who are at risk of familial hyperparathyroidism, including those who are asymptomatic, and they should be followed for potential primary hyperparathyroidism and associated disorders including resultant parathyroid carcinoma.
- Published
- 2015
- Full Text
- View/download PDF